focus -WSS

focus

author：fashion 2025-09-29 20:00:17 - browse：323

Richard Neal(D-MA), Rep. Frank Pallone (D-NJ),Rep. John Yarmuth (D-KY), Rep. Bobby Scott (D-VA) and House Minority Leader Nancy Pelosi (D-CA) attend the weekly press conference in the Capitol building on July 20, 2017 in Washington, DC. They spoke to the media about the efforts to reform the health care bill. -- health policy coverage from STAT — Reps. Richard Neal (D-Mass.), Rep. Frank Pallone (D-N.J.), and Rep. John Yarmuth (D-Ky.) Joe Raedle/Getty Images

WASHINGTON — It’s drug pricing déjà vu: Just as they did in 2019, House Democrats are pushing a bill that would allow Medicare to negotiate dozens of drug prices a year, offer those prices to all insurers, and crack down on price hikes.

Unlike then, Democrats have a starting place: the new bill represents an expansion of the major drug pricing legislation the party passed last year. But the first round of drug price negotiations hasn’t even started yet, and the law is under attack from the pharmaceutical industry in court.

The Democratic leaders of three key House committees put forth the proposal Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： How doctors’ personal politics affect patients

focus

WSS

In the gardens at Boston Children's Hospital, families find sanctuary

Resistance to opioid

Report cites 'urgent' need to recruit more diverse clinical trial participants

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Juul documents reveal insider tactics on political lobbying

AMAs digital advisors table RPM coding reform proposal, again

entertainment

focus

explore

Psychedelics group wrestles with new pharma identity

New Alzheimer's drugs heat up race for early detection blood tests

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Roche’s Alnylam deal shows drug firms interested in heart drugs

BioMarin wins approval for gene therapy to treat hemophilia A

Congress might make insulin pumps more accessible to the blind

Hollywood unions extend contract negotiations for actors

New lawsuit accuses health insurer Cigna of denying claims in bulk

Hollywood unions extend contract negotiations for actors

Biogen says it will cut costs by $700 million, slash 1,000 jobs

hotspot

New lawsuit accuses health insurer Cigna of denying claims in bulk

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Too many hospitalized Covid

Senate panel puts off hardest PBM reforms for another day

Search called off for baby washed away in Pennsylvania flash flood

entertainment

hotspot

focus

leisure time